DEVELOPMENT OF ANTISICKLING COMPOUNDS THAT CHEMICALLY MODIFY, HEMOGLOBIN S SPECIFICALLY WITHIN THE 2,3-DIPHOSPHOGLYCERATE BINDING SITEWALDER JA; WALDER RY; ARNONE A et al.1980; J. MOLEC. BIOL.; GBR; DA. 1980; VOL. 141; NO 2; PP. 195-216; BIBL. 2 P.Article

CLONING OF THE MSPI MODIFICATION ENZYME: THE SITE OF MODIFICATION AND ITS EFFECTS ON CLEAVAGE BY MSPI AND HPAIIWALDER RY; LANGTIMM CJ; RANJIT CHATTERJEE et al.1983; JOURNAL OF BIOLOGICAL CHEMISTRY; ISSN 0021-9258; USA; DA. 1983; VOL. 258; NO 2; PP. 1235-1241; BIBL. 51 REF.Article

MODIFICATION OF HEMOGLOBIN WITH ANALOGS OF ASPIRINZAUGG RH; WALDER JA; WALDER RY et al.1980; J. BIOL. CHEM.; USA; DA. 1980; VOL. 255; NO 7; PP. 2816-2821; BIBL. 19 REF.Article

COMPLEMENTARY CARRIER PEPTIDE SYNTHESIS: GENERAL STRATEGY AND IMPLICATIONS FOR PREBIOTIC ORIGIN OF PEPTIDE SYNTHESISWALDER JA; WALDER RY; HELLER MJ et al.1979; PROC. NATION. ACAD. SCI. USA; USA; DA. 1979; VOL. 76; NO 1; PP. 51-55; BIBL. 14 REF.Article